Enliven Therapeutics, Inc.
ELVNBiotechnology
$45.08+0.67%As of Oct 29vs prior close
- Market cap
- $3.3B
- P/E (TTM)
- –
- From 52W high
- −26.28%
- EPS (LTM)
- -$1.64
- Dividend yield
- 0.00%
Nomior Score
64
Steady ProfileSpeculativeTop 18% of the scored universe
Growth—
Quality57
Value60
Momentum78
Resilience49